Pediatric Cancer Recurrence: AI Improves Risk Prediction
May 6, 2025
Pediatric cancer recurrence poses a significant challenge for young patients and their families, particularly in cases involving brain tumors like gliomas.Recent advancements in AI in medicine are shifting the landscape of relapse risk assessment by utilizing novel approaches to predict the likelihood of recurrence more accurately than traditional methods.
Read more
AI Predicting Brain Cancer Relapse for Pediatric Patients
May 2, 2025
AI predicting brain cancer relapse is a groundbreaking advancement in the field of pediatric oncology, offering a new beacon of hope for patients and their families.Recent research from Mass General Brigham reveals that an artificial intelligence tool can outperform traditional methods in assessing the risk of relapse among children suffering from gliomas.
Read more